Correlation Between Viridian Therapeutics and Ventyx Biosciences

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and Ventyx Biosciences, you can compare the effects of market volatilities on Viridian Therapeutics and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Ventyx Biosciences.

Diversification Opportunities for Viridian Therapeutics and Ventyx Biosciences

0.91

Correlation Coefficient

Viridian Therapeutics  Ventyx Biosciences

Almost no diversification

The 3 months correlation between Viridian and Ventyx is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Ventyx Biosciences go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Ventyx Biosciences

Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.71 times more return on investment than Ventyx Biosciences. However, Viridian Therapeutics is 1.41 times less risky than Ventyx Biosciences. It trades about -0.14 of its potential returns per unit of risk. Ventyx Biosciences is currently generating about -0.2 per unit of risk. If you would invest  1,954  in Viridian Therapeutics on December 29, 2024 and sell it today you would lose (510.00) from holding Viridian Therapeutics or give up 26.1% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Viridian Therapeutics  vs.  Ventyx Biosciences

Viridian Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ventyx Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ventyx Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Viridian Therapeutics and Ventyx Biosciences

The main advantage of trading using opposite Viridian Therapeutics and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.

The idea behind Viridian Therapeutics and Ventyx Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.